These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7551949)

  • 1. Combined modality treatment for stage III non-small cell lung cancer.
    Bonomi P
    Lung Cancer; 1995 Jun; 12 Suppl 2():S41-52. PubMed ID: 7551949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation and simultaneous cisplatin in non-small cell lung cancer.
    Bonomi P
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):739-46. PubMed ID: 8226172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant (induction) treatment for non-small cell lung cancer.
    Ginsberg RJ
    Lung Cancer; 1995 Jun; 12 Suppl 2():S33-40. PubMed ID: 7551948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer.
    Scagliotti GV; Turrisi AT
    Oncologist; 2003; 8(4):361-74. PubMed ID: 12897333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studies.
    Choy H; Gerber DE; Bradley JD; Iyengar P; Monberg M; Treat J; Govindan R; Koustensis A; Barker S; Obasaju C
    Lung Cancer; 2015 Mar; 87(3):232-40. PubMed ID: 25650301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
    Liu D; Zheng X; Chen J; Liu G; Xu Y; Shen Y; Xie L; Zhao W; Jiang G; Fan M
    Lung Cancer; 2015 Sep; 89(3):249-54. PubMed ID: 26118463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group.
    Vansteenkiste J; De Leyn P; Deneffe G; Menten J; Lerut T; Demedts M
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):1-12. PubMed ID: 9504724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
    Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current state of the art in treating stage IIIA (N2) lung cancer.
    Martini N
    Ann Oncol; 1998 Mar; 9(3):243-5. PubMed ID: 9602255
    [No Abstract]   [Full Text] [Related]  

  • 14. Multimodality therapy in unresected stage III non-small cell lung cancer: the American Cooperative Groups' Experience.
    Green MR
    Lung Cancer; 1995 Apr; 12 Suppl 1():S87-94. PubMed ID: 7551938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality treatment for locally advanced non-small cell lung cancer--which control arm?
    Johnson DH
    Lung Cancer; 1994 Mar; 10 Suppl 1():S231-8. PubMed ID: 7522113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801).
    Kawaguchi K; Yokoi K; Niwa H; Ohde Y; Mori S; Okumura S; Shiono S; Ito H; Yano M; Shigemitsu K; Hiramatsu Y; Okami J; Saka H;
    Lung Cancer; 2017 Feb; 104():79-84. PubMed ID: 28213006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group.
    Weiden PL; Piantadosi S
    J Natl Cancer Inst; 1991 Feb; 83(4):266-73. PubMed ID: 1847220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An historical perspective of multi-modality treatment for resectable non-small cell lung cancer.
    Jaklitsch MT; Strauss GM; Healey EA; DeCamp MM; Liptay MJ; Sugarbaker DJ
    Lung Cancer; 1995 Jun; 12 Suppl 2():S17-32. PubMed ID: 7551946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
    Bonomi P; Reddy S; Faber LP
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients.
    Tourani JM; Timsit JF; Delaisement C; Balzon JC; Caubarrere I; Darse J; Geraads A; Lebas FX; Andrieu JM
    Cancer; 1990 Apr; 65(7):1472-7. PubMed ID: 2155697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.